A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

NCT01306630 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Locally Advanced or Metastatic Breast or Colorectal Cancer

Interventions

DRUG: tivozanib (AV-951) and capecitabine (Xeloda®)

Sponsor

AVEO Pharmaceuticals, Inc.